Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in J Neurochem

Retrieve available abstracts of 98 articles:
HTML format



Single Articles


    April 2021
  1. LEE-LIU D, Gonzalez-Billault C
    Neuron-intrinsic origin of hyperexcitability during early pathogenesis of Alzheimer's disease: An Editorial Highlight for "Hippocampal hyperactivity in a rat model of Alzheimer's disease" on https://doi.org/10.1111/jnc.15323.
    J Neurochem. 2021 Apr 28. doi: 10.1111/jnc.15248.
    PubMed     Abstract available


  2. SUN L, Bhawal R, Xu H, Chen H, et al
    The human brain acetylome reveals that decreased acetylation of mitochondrial proteins associates with Alzheimer's disease.
    J Neurochem. 2021 Apr 27. doi: 10.1111/jnc.15377.
    PubMed     Abstract available


  3. VAN DER VELPEN V, Rosenberg N, Maillard V, Teav T, et al
    Sex-specific alterations in NAD+ metabolism in triple transgenic Alzheimer's disease mouse brain assessed by quantitative targeted liquid chromatography - mass spectrometry.
    J Neurochem. 2021 Apr 8. doi: 10.1111/jnc.15362.
    PubMed     Abstract available


    March 2021
  4. BUTLER CA, Thornton P, Brown GC
    CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer's disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion.
    J Neurochem. 2021 Mar 15. doi: 10.1111/jnc.15349.
    PubMed     Abstract available


    February 2021
  5. SOSULINA L, Mittag M, Geis HR, Hoffmann K, et al
    Hippocampal hyperactivity in a rat model of Alzheimer's disease.
    J Neurochem. 2021 Feb 14. doi: 10.1111/jnc.15323.
    PubMed     Abstract available


  6. ARBER C, Alatza A, Leckey CA, Paterson RW, et al
    Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
    J Neurochem. 2021 Feb 4. doi: 10.1111/jnc.15315.
    PubMed     Abstract available


    January 2021
  7. HUANG SJ, Ma YH, Bi YL, Shen XN, et al
    Metabolically healthy obesity and lipids may be protective factors for pathological changes of Alzheimer's disease in cognitively normal adults.
    J Neurochem. 2021 Jan 18. doi: 10.1111/jnc.15306.
    PubMed     Abstract available


  8. GRUNDER G, Cumming P
    Serotonin and amyloid deposition: A link between depression and Alzheimer's disease?: An Editorial Highlight on "Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Abeta production and related pathology in a mouse model of Alzheimer's
    J Neurochem. 2021 Jan 18. doi: 10.1111/jnc.15269.
    PubMed     Abstract available


  9. HARK TJ, Savas JN
    Using stable isotope labeling to advance our understanding of Alzheimer's disease etiology and pathology.
    J Neurochem. 2021 Jan 12. doi: 10.1111/jnc.15298.
    PubMed     Abstract available


    December 2020
  10. HIGHET B, Anekal PV, Ryan B, Murray H, et al
    fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer's disease using an automated quantitative analysis workflow.
    J Neurochem. 2020 Dec 25. doi: 10.1111/jnc.15283.
    PubMed     Abstract available


  11. STOLERO N, Frenkel D
    The Dialog between Neurons and Microglia in Alzheimer's Disease: The Neurotransmitters View.
    J Neurochem. 2020 Dec 12. doi: 10.1111/jnc.15262.
    PubMed     Abstract available


  12. YUEDE CM, Wallace CE, Davis TA, Gardiner WD, et al
    Pimavanserin, a 5HT2A receptor inverse agonist, rapidly suppresses Abeta production and related pathology in a mouse model of Alzheimer's disease.
    J Neurochem. 2020 Dec 5. doi: 10.1111/jnc.15260.
    PubMed     Abstract available


  13. GULYAEVA NV
    Hippocampal hyperglutamatergic signaling matters: Early targeting glutamate neurotransmission as a preventive strategy in Alzheimer's disease: An Editorial Highlight for "Riluzole attenuates glutamatergic tone and cognitive decline in AbetaPP/PS1 mice
    J Neurochem. 2020 Dec 4. doi: 10.1111/jnc.15238.
    PubMed     Abstract available


  14. LI W, Wu M, Zhang Y, Wei X, et al
    Intermittent fasting promotes adult hippocampal neuronal differentiation by activating GSK-3beta in 3xTg-AD mice.
    J Neurochem. 2020;155:697-713.
    PubMed     Abstract available


    November 2020
  15. LI L, Miao M, Chen J, Liu Z, et al
    Role of Tet2 in modulating neuronal morphology and cognition in a mouse model of Alzheimer's disease.
    J Neurochem. 2020 Nov 9. doi: 10.1111/jnc.15234.
    PubMed     Abstract available


  16. VINKLAROVA L, Schmidt M, Benek O, Kuca K, et al
    Friend or enemy? Review of 17beta-HSD10 and its role in human health or disease.
    J Neurochem. 2020;155:231-249.
    PubMed     Abstract available


    October 2020
  17. LIMEGROVER CS, LeVine H 3rd, Izzo NJ, Yurko R, et al
    Alzheimer's Protection Effect of A673T Mutation May Be Driven by Lower Abeta Oligomer Binding Affinity.
    J Neurochem. 2020 Oct 6. doi: 10.1111/jnc.15212.
    PubMed     Abstract available


    September 2020
  18. GAUNITZ S, Tjernberg LO, Schedin-Weiss S
    The N-glycan profile in cortex and hippocampus is altered in Alzheimer s disease.
    J Neurochem. 2020 Sep 28. doi: 10.1111/jnc.15202.
    PubMed     Abstract available


  19. PENA-BAUTISTA C, Alvarez L, Baquero M, Ferrer I, et al
    Plasma isoprostanoids assessment as Alzheimer Disease progression biomarkers.
    J Neurochem. 2020 Sep 12. doi: 10.1111/jnc.15183.
    PubMed     Abstract available


  20. PEREIRA JD, Fraga VG, Santos ALM, das Gracas Carvalho M, et al
    Alzheimer's disease and type 2 diabetes mellitus: a systematic review of proteomic studies.
    J Neurochem. 2020 Sep 9. doi: 10.1111/jnc.15166.
    PubMed     Abstract available


  21. BROSSERON F, Kleemann K, Kolbe CC, Santarelli F, et al
    Interrelations of Alzheimer s disease candidate biomarkers neurogranin, fatty acid binding protein 3 and ferritin to neurodegeneration and neuroinflammation.
    J Neurochem. 2020 Sep 7. doi: 10.1111/jnc.15175.
    PubMed     Abstract available


  22. PEDRINI S, Chatterjee P, Hone E, Martins RN, et al
    High Density Lipoprotein-related cholesterol metabolism in Alzheimer's Disease.
    J Neurochem. 2020 Sep 5. doi: 10.1111/jnc.15170.
    PubMed     Abstract available


    August 2020
  23. WANG L, Liu S, Xu J, Watanabe N, et al
    Emodin inhibits Abeta42 aggregation and improves cognitive deficits in Alzheimer's disease transgenic mice.
    J Neurochem. 2020 Aug 16. doi: 10.1111/jnc.15156.
    PubMed     Abstract available


  24. MOSSER S, Gerber H, Fraering PC
    Identification of truncated C-terminal fragments of the Alzheimer's disease amyloid protein precursor derived from sequential proteolytic pathways.
    J Neurochem. 2020 Aug 5. doi: 10.1111/jnc.15143.
    PubMed     Abstract available


    July 2020
  25. SIMOES-PIRES EN, Ferreira ST, Linden R
    Roles of glutamate receptors in a novel in vitro model of early, comorbid cerebrovascular and Alzheimer's diseases.
    J Neurochem. 2020 Jul 19. doi: 10.1111/jnc.15129.
    PubMed     Abstract available


  26. MARTINS TS, Trindade D, Vaz M, Campelo I, et al
    Diagnostic and therapeutic potential of exosomes in Alzheimer's disease.
    J Neurochem. 2020 Jul 3. doi: 10.1111/jnc.15112.
    PubMed     Abstract available


  27. SATHE G, Albert M, Darrow J, Saito A, et al
    Quantitative proteomic analysis of the frontal cortex in Alzheimer's disease.
    J Neurochem. 2020 Jul 2. doi: 10.1111/jnc.15116.
    PubMed     Abstract available


  28. GUNN AP, Wong BX, McLean C, Fowler C, et al
    Increased glutaminyl cyclase activity in brain of Alzheimer's disease individuals.
    J Neurochem. 2020 Jul 2. doi: 10.1111/jnc.15114.
    PubMed     Abstract available


    May 2020
  29. DE FREITAS GB, Lourenco MV, De Felice FG
    Protective actions of exercise-related FNDC5/Irisin in memory and Alzheimer's disease.
    J Neurochem. 2020 May 12. doi: 10.1111/jnc.15039.
    PubMed     Abstract available


  30. MUNTER LM
    The lipid component of Alzheimer's disease research: An Editorial Highlight for "Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice" on https://do
    J Neurochem. 2020 May 6. doi: 10.1111/jnc.15025.
    PubMed     Abstract available


    April 2020
  31. FONTANA IC, Zimmer AR, Rocha AS, Gosmann G, et al
    Amyloid-beta oligomers in cellular models of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15030.
    PubMed     Abstract available


  32. LI Z, Zhu H, Guo Y, Du X, et al
    Gut microbiota regulate cognitive deficits and amyloid deposition in a model of Alzheimer's disease.
    J Neurochem. 2020 Apr 22. doi: 10.1111/jnc.15031.
    PubMed     Abstract available


  33. BULLAIN S, Doody R
    What works and what doesn't work in Alzheimer's disease? From interventions on risk factors to anti-amyloid trials.
    J Neurochem. 2020 Apr 11. doi: 10.1111/jnc.15023.
    PubMed     Abstract available


    March 2020
  34. RAJAEI S, Karima S, Sepasi Tehrani H, Shateri S, et al
    Conformational Change and GTPase Activity of Human Tubulin: A Comparative Study on Alzheimer's Disease and Healthy Brain.
    J Neurochem. 2020 Mar 20. doi: 10.1111/jnc.15009.
    PubMed     Abstract available


  35. LI S, Selkoe DJ
    A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Ab oligomers from Alzheimer brain.
    J Neurochem. 2020 Mar 17. doi: 10.1111/jnc.15007.
    PubMed     Abstract available


  36. LI B, Liu J, Gu G, Han X, et al
    Impact of neural stem cell-derived extracellular vesicles on mitochondrial dysfunction, sirtuin 1 level and synaptic deficits in Alzheimer's disease.
    J Neurochem. 2020 Mar 7. doi: 10.1111/jnc.15001.
    PubMed     Abstract available


  37. KAYA I, Jennische E, Lange S, Baykal AT, et al
    Brain Region Specific Amyloid Plaque Associated Myelin Lipid Loss, APOE Deposition and Disruption of the Myelin Sheath in Familial Alzheimer's Disease Mice.
    J Neurochem. 2020 Mar 5. doi: 10.1111/jnc.14999.
    PubMed     Abstract available


    February 2020
  38. HIERRO-BUJALANCE C, Del Marco A, Ramos-Rodriguez JJ, Infante-Garcia C, et al
    Cell proliferation and neurogenesis alterations in Alzheimer's disease and diabetes mellitus mixed murine models.
    J Neurochem. 2020 Feb 18. doi: 10.1111/jnc.14987.
    PubMed     Abstract available


    January 2020
  39. HOU TY, Zhou Y, Zhu LS, Wang X, et al
    Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
    J Neurochem. 2020 Jan 17:e14961. doi: 10.1111/jnc.14961.
    PubMed     Abstract available


    November 2019
  40. IMAMURA O, Arai M, Dateki M, Oishi K, et al
    Donepezil-induced oligodendrocyte differentiation is mediated through estrogen receptors.
    J Neurochem. 2019 Nov 28. doi: 10.1111/jnc.14927.
    PubMed     Abstract available


    October 2019
  41. MICHNO W, Wehrli P, Meier S, Sehlin D, et al
    Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Abeta Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.
    J Neurochem. 2019 Oct 12. doi: 10.1111/jnc.14888.
    PubMed     Abstract available


    September 2019
  42. WIJASA TS, Sylvester M, Brocke-Ahmadinejad N, Schwartz S, et al
    Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's disease.
    J Neurochem. 2019 Sep 14. doi: 10.1111/jnc.14870.
    PubMed     Abstract available


    August 2019
  43. ZHU B, Li Z, Qian PY, Herrup K, et al
    Marine bacterial extracts as a new rich source of drugs against Alzheimer's disease.
    J Neurochem. 2019 Aug 5. doi: 10.1111/jnc.14847.
    PubMed     Abstract available


  44. SORGDRAGER FJH, Vermeiren Y, Van Faassen HJR, Van Der Ley CP, et al
    Age- and Disease-Specific Changes of the Kynurenine Pathway in Parkinson's and Alzheimer's Disease.
    J Neurochem. 2019 Aug 3. doi: 10.1111/jnc.14843.
    PubMed     Abstract available


    June 2019
  45. NICHOLS MR, St-Pierre MK, Wendeln AC, Makoni NJ, et al
    Inflammatory mechanisms in neurodegeneration.
    J Neurochem. 2019;149:562-581.
    PubMed     Abstract available


    May 2019
  46. GARCIA-AYLLON MS, Monge-Argiles JA, Monge-Garcia V, Navarrete F, et al
    Measurement of CSF proportional, variant-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer's disease.
    J Neurochem. 2019 May 11. doi: 10.1111/jnc.14719.
    PubMed     Abstract available


    April 2019
  47. MURAMATSU I, Uwada J, Yoshiki H, Sada K, et al
    Novel regulatory systems for acetylcholine release in rat striatum and anti-Alzheimer's disease drugs.
    J Neurochem. 2019 Apr 10. doi: 10.1111/jnc.14701.
    PubMed     Abstract available


    February 2019
  48. JHA NK, Jha SK, Kar R, Nand P, et al
    Nuclear Factor-Kappa beta as a therapeutic target for Alzheimer's disease.
    J Neurochem. 2019 Feb 25. doi: 10.1111/jnc.14687.
    PubMed     Abstract available


    January 2019
  49. HASCUP ER, Broderick SO, Russell MK, Fang Y, et al
    Diet-induced insulin resistance elevates hippocampal glutamate as well as VGLUT1 and GFAP expression in AbetaPP/PS1 mice.
    J Neurochem. 2019;148:219-237.
    PubMed     Abstract available


    December 2018
  50. CLINE EN, Das A, Bicca MA, Mohammad SN, et al
    A Novel Crosslinking Protocol Stabilizes Amyloid beta Oligomers Capable of Inducing Alzheimer's-Associated Pathologies.
    J Neurochem. 2018 Dec 18. doi: 10.1111/jnc.14647.
    PubMed     Abstract available


    November 2018
  51. CILENTO EM, Jin L, Stewart T, Shi M, et al
    Mass Spectrometry: A Platform for Biomarker Discovery and Validation for Alzheimer's and Parkinson's Diseases.
    J Neurochem. 2018 Nov 26. doi: 10.1111/jnc.14635.
    PubMed     Abstract available


    October 2018
  52. CHANEY A, Williams SR, Boutin H
    In vivo Molecular Imaging of Neuroinflammation in Alzheimer's disease.
    J Neurochem. 2018 Oct 19. doi: 10.1111/jnc.14615.
    PubMed     Abstract available


  53. CISTERNAS P, Zolezzi JM, Martinez M, Torres VI, et al
    Wnt-induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease.
    J Neurochem. 2018 Oct 9. doi: 10.1111/jnc.14608.
    PubMed     Abstract available


    September 2018
  54. BUTTERFIELD DA, Boyd-Kimball D
    Redox Proteomics and Amyloid beta-Peptide: Insights into Alzheimer Disease.
    J Neurochem. 2018 Sep 14. doi: 10.1111/jnc.14589.
    PubMed     Abstract available


  55. NORRIS CM
    Calcineurin: directing the damage in Alzheimer disease: An Editorial for 'Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain' on doi: 10.1111/jnc.14469.
    J Neurochem. 2018 Sep 7. doi: 10.1111/jnc.14475.
    PubMed     Abstract available


    July 2018
  56. GRANGER MW, Liu H, Fowler CF, Blanchard AP, et al
    Distinct disruptions in Land's cycle remodeling of glycerophosphocholines in murine cortex mark symptomatic onset and progression in two Alzheimer's Disease mouse models.
    J Neurochem. 2018 Jul 24. doi: 10.1111/jnc.14560.
    PubMed     Abstract available


    May 2018
  57. HOPP SC, Bihlmeyer NA, Corradi JP, Vanderburg C, et al
    Neuronal calcineurin transcriptional targets parallel changes observed in Alzheimer disease brain.
    J Neurochem. 2018 May 28. doi: 10.1111/jnc.14469.
    PubMed     Abstract available


    April 2018
  58. CALVO-FLORES GUZMAN B, Vinnakota C, Govindpani K, Waldvogel H, et al
    The GABAergic System as a Therapeutic Target for Alzheimer's Disease.
    J Neurochem. 2018 Apr 12. doi: 10.1111/jnc.14345.
    PubMed     Abstract available


    March 2018
  59. MARWARHA G, Schommer J, Lund J, Schommer T, et al
    Palmitate-induced C/EBP homologous protein activation leads to NF-kappaB-mediated increase in BACE1 activity and amyloid beta genesis.
    J Neurochem. 2018;144:761-779.
    PubMed     Abstract available


  60. BAZZIGALUPPI P, Beckett TL, Koletar MM, Lai AY, et al
    Early-stage attenuation of phase-amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease.
    J Neurochem. 2018;144:669-679.
    PubMed     Abstract available


  61. GORELICK PB
    Prevention of cognitive impairment: scientific guidance and windows of opportunity.
    J Neurochem. 2018;144:609-616.
    PubMed     Abstract available


    February 2018
  62. KWAKOWSKY A, Calvo-Flores Guzman B, Pandya M, Turner C, et al
    GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.
    J Neurochem. 2018 Feb 27. doi: 10.1111/jnc.14325.
    PubMed     Abstract available


  63. SAADIPOUR K, Manucat-Tan NB, Lim Y, Keating DJ, et al
    p75 neurotrophin receptor interacts with and promotes BACE1 localization in endosomes aggravating amyloidogenesis.
    J Neurochem. 2018;144:302-317.
    PubMed     Abstract available


    January 2018
  64. GARNER B, Ooi L
    Wnt is here! Could Wnt signalling be promoted to protect against Alzheimer disease?: An Editorial for 'Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20- APP transgenic and wild-type mice' on do
    J Neurochem. 2018 Jan 26. doi: 10.1111/jnc.14276.
    PubMed     Abstract available


  65. PAN Y, Choy KHC, Marriott PJ, Chai SY, et al
    Reduced blood-brain barrier expression of fatty acid-binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega-3 fatty acid diets.
    J Neurochem. 2018;144:81-92.
    PubMed     Abstract available


    December 2017
  66. NUCERA A, Hachinski V
    Cerebrovascular and alzheimer disease: fellow travellers or partners in crime?
    J Neurochem. 2017 Dec 21. doi: 10.1111/jnc.14283.
    PubMed     Abstract available


  67. KACZMARCZYK R, Tejera D, Simon BJ, Heneka MT, et al
    Microglia modulation through external vagus nerve stimulation in a murine model of Alzheimer's disease.
    J Neurochem. 2017 Dec 21. doi: 10.1111/jnc.14284.
    PubMed     Abstract available


  68. TAPIA-ROJAS C, Inestrosa NC
    Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    J Neurochem. 2017 Dec 14. doi: 10.1111/jnc.14278.
    PubMed     Abstract available


  69. BRACZYNSKI AK, Schulz JB, Bach JP
    Vaccination strategies in tauopathies and synucleinopathies.
    J Neurochem. 2017;143:467-488.
    PubMed     Abstract available


  70. KAWANO H, Oyabu K, Yamamoto H, Eto K, et al
    Astrocytes with previous chronic exposure to amyloid beta-peptide fragment 1-40 suppress excitatory synaptic transmission.
    J Neurochem. 2017;143:624-634.
    PubMed     Abstract available


  71. COLVIN BA, Rogers VA, Kulas JA, Ridgway EA, et al
    The conformational epitope for a new Abeta42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.
    J Neurochem. 2017;143:736-749.
    PubMed     Abstract available


    November 2017
  72. MOLNAR E
    New tool to tackle Alzheimer's disease: amyloid-beta protofibril-selective antibody AbSL: An Editorial Highlight for 'The conformational epitope for a new Abeta42 protofibril-selective antibody partially overlaps with the peptide N-terminal region' on
    J Neurochem. 2017 Nov 23. doi: 10.1111/jnc.14240.
    PubMed     Abstract available


  73. KUSAKARI S, Nawa M, Sudo K, Matsuoka M, et al
    Calmodulin-like skin protein protects against spatial learning impairment in a mouse model of Alzheimer disease.
    J Neurochem. 2017 Nov 21. doi: 10.1111/jnc.14258.
    PubMed     Abstract available


  74. NDAY CM, Eleftheriadou D, Jackson G
    Shared Pathological Pathways of Alzheimer's disease with Specific Comorbidities: Current Perspectives and Interventions.
    J Neurochem. 2017 Nov 21. doi: 10.1111/jnc.14256.
    PubMed     Abstract available


  75. CHANEY A, Bauer M, Bochicchio D, Smigova A, et al
    Longitudinal investigation of neuroinflammation and metabolite profiles in the APPswe xPS1Deltae9 transgenic mouse model of Alzheimer's disease.
    J Neurochem. 2017 Nov 10. doi: 10.1111/jnc.14251.
    PubMed     Abstract available


    October 2017
  76. BEHL C, Ziegler C
    Beyond Amyloid - Widening the View on Alzheimer's Disease.
    J Neurochem. 2017 Oct 20. doi: 10.1111/jnc.14137.
    PubMed     Abstract available


  77. WILLIAM REBECK G, Pak DTS
    A mobile APP for sharing contacts on your cell: An Editorial Highlight for 'The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system' on page 11.
    J Neurochem. 2017;143:9-10.
    PubMed     Abstract available


  78. SOSA LJ, Caceres A, Dupraz S, Oksdath M, et al
    The physiological role of the amyloid precursor protein as an adhesion molecule in the developing nervous system.
    J Neurochem. 2017;143:11-29.
    PubMed     Abstract available


    August 2017
  79. ROUBROEKS JAY, Smith RG, van den Hove DLA, Lunnon K, et al
    Epigenetics and DNA methylomic profiling in Alzheimer's disease and other neurodegenerative diseases.
    J Neurochem. 2017 Aug 14. doi: 10.1111/jnc.14148.
    PubMed     Abstract available


    July 2017
  80. LAI AY, McLaurin J
    Rho-associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease.
    J Neurochem. 2017 Jul 19. doi: 10.1111/jnc.14130.
    PubMed     Abstract available


  81. CHENG S, Wani WY, Hottman DA, Jeong A, et al
    Haplodeficiency of Cathepsin D does not affect cerebral amyloidosis and autophagy in APP/PS1 transgenic mice.
    J Neurochem. 2017;142:297-304.
    PubMed     Abstract available


  82. NIGAM SM, Xu S, Kritikou JS, Marosi K, et al
    Exercise and BDNF reduce Abeta production by enhancing alpha-secretase processing of APP.
    J Neurochem. 2017;142:286-296.
    PubMed     Abstract available


    May 2017
  83. TSE KH, Herrup K
    Re-imagining Alzheimer's disease - the diminishing importance of amyloid and a glimpse of what lies ahead.
    J Neurochem. 2017 May 26. doi: 10.1111/jnc.14079.
    PubMed     Abstract available


  84. COULSON EJ, Bartlett PF
    An exercise path to preventing Alzheimer's disease: An Editorial Highlight on 'Exercise and BDNF reduce Ab production by enhancing alpha-secretase processing of APP'.
    J Neurochem. 2017 May 18. doi: 10.1111/jnc.14038.
    PubMed     Abstract available


  85. SILMAN I, Sussman JL
    Recent developments in structural studies on acetylcholinesterase.
    J Neurochem. 2017 May 15. doi: 10.1111/jnc.13992.
    PubMed     Abstract available


  86. RODRIGUEZ L, Mohamed NV, Desjardins A, Lippe R, et al
    Rab7A regulates tau secretion.
    J Neurochem. 2017;141:592-605.
    PubMed     Abstract available


    April 2017
  87. ARENDT T, Stieler J, Ueberham U
    Is sporadic Alzheimer's disease a developmental disorder?
    J Neurochem. 2017 Apr 11. doi: 10.1111/jnc.14036.
    PubMed     Abstract available


    March 2017
  88. PUCHOWICZ MA, Seyfried TN
    Novel ketone body therapy for managing Alzheimer's disease: An Editorial Highlight for Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's diseas
    J Neurochem. 2017 Mar 15. doi: 10.1111/jnc.13979.
    PubMed     Abstract available


  89. BRANDT R, Bakota L
    Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection.
    J Neurochem. 2017 Mar 7. doi: 10.1111/jnc.14011.
    PubMed     Abstract available


    February 2017
  90. GRALLE M
    The neuronal insulin receptor in its environment.
    J Neurochem. 2017;140:359-367.
    PubMed     Abstract available


    January 2017
  91. PAWLOSKY RJ, Kemper MF, Kashiwaya Y, King MT, et al
    Effects of a dietary ketone ester on hippocampal glycolytic and TCA cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease.
    J Neurochem. 2017 Jan 18. doi: 10.1111/jnc.13958.
    PubMed     Abstract available


  92. YAMIN G, Teplow DB
    Pittsburgh Compound-B (PiB) binds amyloid beta-protein protofibrils.
    J Neurochem. 2017;140:210-215.
    PubMed     Abstract available


    December 2016
  93. WHYTE LS, Lau AA, Hemsley KM, Hopwood JJ, et al
    Endo-lysosomal and autophagic dysfunction: A driving factor in Alzheimer's disease?
    J Neurochem. 2016 Dec 27. doi: 10.1111/jnc.13935.
    PubMed     Abstract available


  94. SALMINEN A, Kauppinen A, Kaarniranta K
    Hypoxia/ischemia activate processing of Amyloid Precursor Protein: impact of vascular dysfunction in the pathogenesis of Alzheimer's disease.
    J Neurochem. 2016 Dec 17. doi: 10.1111/jnc.13932.
    PubMed     Abstract available


  95. YI B, Sahn JJ, Ardestani PM, Evans AK, et al
    Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuro-inflammation in experimental models of Alzheimer's disease.
    J Neurochem. 2016 Dec 7. doi: 10.1111/jnc.13917.
    PubMed     Abstract available


    November 2016
  96. ELLISON EM, Abner EL, Lovell MA
    Multiregional analysis of global 5-methylcytosine and 5-hydroxymethylcytosine throughout the progression of Alzheimer's disease.
    J Neurochem. 2016 Nov 27. doi: 10.1111/jnc.13912.
    PubMed     Abstract available


    September 2016
  97. IMAMURA O, Arai M, Dateki M, Takishima K, et al
    Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis.
    J Neurochem. 2016 Sep 24. doi: 10.1111/jnc.13856.
    PubMed     Abstract available


  98. MURAMATSU I, Yoshiki H, Uwada J, Masuoka T, et al
    Pharmacological evidence of specific acetylcholine transport in rat cerebral cortex and other brain regions.
    J Neurochem. 2016 Sep 14. doi: 10.1111/jnc.13843.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: